Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy

Pharmacology and Toxicology

Volumn 78, Issue 6, 1996, Pages 387-391

  Manninen, Auli ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; NIFEDIPINE; THROMBOXANE A2;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; ORAL DRUG ADMINISTRATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0029932995     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00223.x     Document Type: Article

References (26)

1. Ahmed, Y., M. H. F. Sullivan & M. G. Elder: Increased platelet turnover in a patient with previous recurrent preeclampsia and failure of aspirin therapy. Case report. Brit. J. Obstet. Gynaecol. 1991, 98, 218-220.
2. Ballegeer, V. C., B. Spitz, L. A. De Baene, A. F. Van Assche, M. Hidajat & A. M. Criel: Platelet activation and vascular damage in gestational hypertension. Amer. J. Obstet. Gynecol. 1992, 166, 629-633.
3. Carter, A. J. & S. Heptinstall: Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate. Thromb. Haemost. 1985, 612-616.
4. 14C-arachidonic acid in human platelets in vitro. Prostagl. Leukotr. Med. 1985, 17, 191-198.
5. Dale, J., K. H. Landmark & E. Myhre: The effects of nifedipine, a calcium antagonist, on platelet function. Amer. Heart J. 1983, 105, 103-105.
6. Davi, G., S. Novo, M. Fiore, A. Foderà, A. Mattina, A. Mazzola & A. Strano: Effects by nifedipine on thromboxane synthesis in vitro and in vivo. Thromb. Res. 1982, 28, 837-842.
7. de Jong, C. L. D., G. A. Dekker & B. M. Sibai: The renin-angiotensin-aldosterone system in preeclampsia. Clin. Perinatol. 1991, 18, 683-711.
8. Fitzgerald, D. J., G. Mayo, F. Gatella, S. S. Entman & G. A. Fitz-Gerald: Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. Amer. J. Obstet. Gvnecol. 1987, 157, 325-330.
9. Hallam, T. J. & T. J. Rink: Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator Quin 2. J. Physiol. 1985, 368, 131-146.
10. Hiroki, T, T. Inove, T. Yoshida & K. Arakawa: Effect of the calcium antagonistic agent nifedipine on platelet aggregation response to exercise in patients with angina pectoris. Arzneimittelforsch. 1982, 32, 1572-1574.
11. Holmsen, H.: Significance of testing platelet functions in vitro. Eur. J. Clin. Invest. 1994, 24 (Suppl. 1), 3-8.
12. Johnsson, H.: Effects by nifedipine (Adalat®) on platelet function in vitro and in vivo. Thromb. Res. 1981, 21, 523-528.
13. 2 production in whole blood in gestational hypertension and pre-eclampsia. Brit. J. Obstet. Gynaecol. 1991, 98, 1239-1244.
14. Mehta, P., J. Mehta, N. Ostrowski & L. Brigmon: Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in sub-treshold concentrations. J Lab. Clin. Med. 1983, 102, 332-339.
15. Moore, J. B., B. L. Fuller, R. Falotico & E. L. Tolman: Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers. Thromb. Res. 1985, 40, 401-411.
16. Morrison, R., J. Crawford, M. MacPherson & S. Heptinstall: Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thromb. Haemost. 1985, 54, 607-611.
17. 1α, and its interaction with indomethacin. Eur. J. Clin. Pharmacol. 1985, 29, 413-416.
18. Rink, T. J. & T. J. Hallam: What turns platelets on? Trends Biochem. Sci. 1984, 9, 215-219.
19. Seppälä, E., O. Pora & T. Metsä-Ketelä: A modified method for extraction and purification of prostaglandins with resin XAD-2. Prostagl. Leukotr. Med. 1984, 14, 235-241.
20. Splawinska, B., A. Skret, R. Palczak, J. Janeczko, W. Furmaga & J. Splawinski: Whole blood platelet aggregation in normal pregnancy and pre-eclampsia. Clin. Exp. Hypertens. 1987, B6, 311-319.
21. Wallenburg, H. C. S., G. A. Dekker, J. W. Makovitz & P. Rotmans: Low-dose aspirin prevents pregnancy induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986, i, 1-3.
22. Walsh, S. W.: Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Amer. J. Obstet. Gynecol. 1985, 152, 335-340.
23. Watanabe, N., S. Kamei, A. Ohkudo, M. Yamanaka, S. Ohsawa, K. Makino & K. Tokudo: Urinary protein as measured with a pyrogallol red-molybdate complex manually and in a Hitachi 726 automated analyzer. Clin. Chem. 1986, 32, 1551-1554.
24. Viinikka, L., A.-L. Hartikainen-Sorri, R. Lumme, V. Hiilesmaa & O. Ylikorkala: Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. Brit. J. Obstet. Gynaecol. 1993, 100, 809-815.
25. Villar, J., J. Repke, L. Markush, W. Calvert & G. Rhoods: The measuring of blood pressure during pregnancy. Amer. J. Obstet. Gynecol. 1989, 161, 1019-1024.
26. Zschauer, A., C. van Breemen, F. R. Bühler & M. T. Nelson: Calcium channels in thrombin activated human platelet membrane. Nature 1988, 344, 703-705.